Panbela Therapeutics CEO Jennifer Simpson's 2020 pay jumps 62% to $1.7M
Panbela Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 15, 2021
Panbela Therapeutics reported fiscal year 2020 executive compensation information on April 15, 2021.
In 2020, three executives at Panbela Therapeutics received on average a compensation package of $919K, a 73% increase compared to previous year.
Average pay of disclosed executives at Panbela Therapeutics
Jennifer K. Simpson, Chief Executive Officer, received $1.7M in total. 87% of Simpson's compensation, or $1.5M, was in option awards. Simpson also received $79K in non-equity incentive plan and $146K in salary.
Michael T. Cullen, Chairman, received a compensation package of $611K, which decreased by 7% compared to previous year. 52% of the compensation package, or $316K, was in salary.
Susan Horvath, Chief Financial Officer, earned $414K in 2020, a 3% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 15, 2021.